Contribute
CONNECT:

research

Clinton's Drug Price Plan Could Actually Raise Prices!

- December 5, 2015

In A New Ad, Clinton Is Claiming She Wants To Reign In Drug Costs And Price Gouging. CLINTON: "For Lin's family the big stress is paying $400 a month in medical and drug costs for Aiden. For other families it is higher deductibles, premiums, and co-pay's that keep adding up. That's why we've got to crack down on price gouging, cap out-of-pocket costs, and fast track approval of less expensive generic drugs. Because we've got to get health care costs under control for Lin's family and for yours. I'm Hillary Clinton and I approve this message." (Hillary Clinton, "Aidan," Hillary Clinton Youtube Channel, Accessed 12/5/15)

Click Here To Watch

CLINTON'S "FEEL-GOOD" AND "ASTONISHINGLY NAÏVE" DRUG PRICE PLAN COULD LEAD TO HIGHER PRICES

Clinton's Drug Price Plan Is A "Feel-Good Idea" That "Would Create Perverse Incentives That Could Raise Instead Of Lower The Costs Of Developing New Drugs." "It's a feel-good idea that calls on the companies to account for their claims that they are research entities. But when I ran it by some health economists and other health policy experts, several strongly disliked the idea because it misunderstands the diversity of companies in the pharmaceutical industry. They say it would create perverse incentives that could raise instead of lower the costs of developing new drugs." (Margot Sanger-Katz, "Why Some Policy Experts Question Clinton's Plan To Contain Drug Costs," The New York Times' The Upshot , 9/22/15)

"It's Not At All Clear That Clinton's Proposals - Some Of Which Have Been Mentioned For Decades" Would Lower Out-Of-Pocket Costs. "But while surveys show that health costs, and particularly drug costs, are a top concern for many voters, it's not at all clear that Clinton's proposals - some of which have been mentioned for decades - would provide an actual cure."(Julie Rovner, "Does Hillary Clinton Have The Prescription For Out-Of-Pocket Costs," Kaiser Health News , 9/25/15)

  • Clinton's Plan To Limit "Out-Of-Pocket Spending" On Pharmaceuticals Is Already A Part Of ObamaCare. "Clinton's drug costs plan would limit patients' out-of-pocket spending on pharmaceutical treatment to $250 a month, or $3,000 a year. ObamaCare, also known as the Affordable Care Act, limited total out-of-pocket medical spending to $6,600 a year for an individual, and $13,200 for a family." (Anna Edney, "Clinton Promises Health Insurance Merger Scrutiny In Policy Plan," Bloomberg , 9/23/15)

Amitabh Chandra, Public Policy Professor At Harvard University: Clinton's Plan Is An "Astonishingly Naïve Approach" That Could Result In Wasteful Research Spending And Do Nothing To Lower Prices. "'This is an astonishingly naïve approach,' said Amitabh Chandra, a professor of public policy at Harvard University, in an email. He argues that the plan could encourage wasteful research spending without necessarily doing much about the prices charged for medications." (Margot Sanger-Katz, "Why Some Policy Experts Question Clinton's Plan To Contain Drug Costs,," The New York Times' The Upshot , 9/22/15)

Ed Kaplan, Sr. V.P Of The Segal Group: Clinton's Plan "Doesn't Get To The Heart Of The Matter," And "Capping The 'Employee's Exposure" To The Cost Of The Drug Does Nothing To Help The Employer, Who Will Pick Up The Tab." "Ms. Clinton's plan 'doesn't get to the heart of the matter,' Mr. Kaplan said. Capping the 'employee's exposure' to the cost of the drug does nothing to help the employer, who will pick up the tab, he said." (Shelby Livingston, "Hillary Clinton's Prescription Drug Plan Not What The Doctor Ordered," Business Insurance , 9/23/15)

Steve Wojcik, V.P. Of Policy At The National Business Group On Health In Washington: Clinton's Plan "Doesn't Solve The Problem" And "The Price Of The Medication Is Still Being Absorbed By The (Health) Plan And Will Be Reflected Somehow In The Premiums." "The $250 cap on out-of-pocket expenses would give immediate relief to individuals taking expensive medications, but 'it doesn't solve the problem,' said Steve Wojcik, vice president of public policy at the National Business Group on Health in Washington. 'The price of the medication is still being absorbed by the (health) plan and will be reflected somehow in the premiums,' he said." (Shelby Livingston, "Hillary Clinton's Prescription Drug Plan Not What The Doctor Ordered," Business Insurance , 9/23/15)

DESPITE CLINTON'S CLAIM TO REIGN IN PHARMACEUTICAL COMPANIES, SHE IS HAPPY TO TAKE THEIR MONEY

The Hill: "Hillary Clinton Has Received More Campaign Cash From Drug Companies Than Any Candidate In Either Party." "Democratic presidential frontrunner Hillary Clinton has received more campaign cash from drug companies than any candidate in either party, even as she proudly declares the industry is one of her biggest enemies." (Sarah Ferris, "Clinton Tops 2016 Field In Drug Industry Donations," The Hill, 10/17/15)

  • "Clinton Accepted $164,315 In The First Six Months Of The Campaign From Drug Companies, Far More Than The Rest Of The 2016 Field." (Sarah Ferris, "Clinton Tops 2016 Field In Drug Industry Donations," The Hill, 10/17/15)

Lobbyists That Represent Drug And Oil Companies Are Raising "Stacks Of Money" For Clinton's Campaign. "Hillary Clinton took aim this week at the pharmaceutical industry and the Keystone oil pipeline. But that doesn't mean the Democratic presidential front-runner isn't enjoying the support of lobbyists representing drug and oil companies in Washington, many of whom are helping raise stacks of money for her campaign." (Catherine Ho, "Clinton Takes Aim At Pharma, Keystone - But Industry Lobbyists Still Provide Campaign Cash," The Washington Post's Power Post , 9/24/15)

The Boston Globe : Clinton Donors Include Bruce Cozadd and Robert McKague Two Senior Executives Of Jazz Pharmaceuticals Who Recently Imposed An 800% Price Hike On One Of Its Drugs. " The donors also include two senior executives of a company that recently imposed a massive price increase on one of its drugs… Clinton, like Sanders, has taken a hard line against the pharmaceutical industry. She has already outlined a plan to crack down on drug prices. At the same time, she has accepted significant contributions from individual donors. She received contributions, for example, from two executives at Jazz Pharmaceuticals, which raised the price of a drug used to treat sleep disorders by more than 800 percent, from roughly $2 to $19 a pill. Each of the executives, chief executive Bruce Cozadd and Robert McKague, a senior vice president, contributed the maximum individual amount, $2,700." (David Nather, "Clinton Takes In Big Money From Drug Industry," The Boston Globe , 10/16/15)


Previous post

Clinton Backpedals On Promise Not To Raise Middle Class Taxes, Calls It A "Goal"

Next post

A $275 Billion Union Payoff
Republican National Committee

Connect With Us

Republican National Committee
Chairwoman Ronna McDaniel
News & Videos
  • 310 First Street SE, Washington, DC 20003
  • 202-863-8500

By providing your phone number, you are consenting to receive calls and SMS/MMS msgs, including autodialed and automated calls and texts, to that number from the Republican National Committee. Msg&data rates may apply. Terms & conditions/privacy policy apply 80810-info.com.

Paid for by the Republican National Committee. Not Authorized By Any Candidate Or Candidate's Committee. www.gop.com

By providing your phone number, you are consenting to receive calls and SMS/MMS msgs, including autodialed and automated calls and texts, to that number from the Republican National Committee. Msg&data rates may apply. Terms & conditions/privacy policy apply 80810-info.com.

Paid for by the Republican National Committee.
Not Authorized By Any Candidate Or Candidate's Committee. www.gop.com